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Disrupted sleep is considered a patient outcome sensitive to oncology nursing care and can lead to a variety of physical 
and psychologic dysfunctions, such as insomnia, chronic pain, respiratory distress, obesity, stress, and anxiety. Although 
sleep disturbances have been studied in recipients of hematopoietic stem cell transplantations (HSCTs), these studies have 
not examined the acute phase of transplantation. The current study aimed to identify the level of sleep disturbance in this 
patient population, identify factors contributing to decreased ability to sleep for hospitalized recipients of HSCT, and com-
pare the differences in sleep disturbance between age, gender, type of transplantation, and initial stem cell transplantation 
versus readmission for transplantation-associated complications. Among the 69 patients studied, 26% reported clinical 
insomnia, as measured by the Insomnia Severity Index, and 74% had some degree of insomnia. Patient characteristics were 
not significantly associated with insomnia scores. Patients reported bathroom use as the most frequent reason for sleep 
disruption (85%). These findings suggest that sleep disturbances are common in hospitalized patients undergoing HSCT, 
and strategies to reduce disruptions are needed to improve patient outcomes.
Sleep Disturbance in Hospitalized 
Recipients of Stem Cell Transplantation
At a Glance
F Sleep disturbances are understudied in recipients of hema-
topoietic stem cell transplantations (HSCTs).
F In a sample of 69 adults undergoing HSCT for hematologic 
malignancies, the majority reported some degree of insom-
nia as measured by the Insomnia Severity Index.
F Toileting needs and staff interruptions are areas to improve 
practice and promote sleep quality in this population.
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O
ncology nurses, including nurses in the hematopoi-
etic stem cell transplantation (HSCT) unit, become 
experts in the practice of holistic assessment and 
the management of cancer symptoms and their 
treatments. Assessment skills are established by 
oncology nurses and fine-tuned through experience. Nurses 
have the distinct ability to influence patient-centered outcomes 
such as cancer and treatment-related symptoms (Given & Sher-
wood, 2005). In the HSCT recipient population, the threat of 
disturbed sleep from lengthy hospitalization, multiple medica-
tions and fluids, unfamiliar surroundings, and environmental 
influences is an area nurses can and should improve to better 
the patient experience.
Background
Sleep is an essential component of a healthy life. Disrupted 
sleep can lead to a variety of physical and psychological dys-
functions, including insomnia, chronic pain, respiratory dys-
function, obesity, stress, and anxiety (Friese, 2008). Patients 
with cancer often are affected by side effects such as pain 
or depression that can manifest as insomnia. They also can 
experience sleep deprivation from side effects of the treat-
ment, such as anemia, daytime fatigue, and the physiologic 
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effects of medications (O’Donnell, 2004). Hospitalized patients 
experience more sleep disturbances than adults in the general 
population (Flaherty, 2008; Moraes de Almondes, Bezerra Mota, 
& Fontenele Araújo, 2008). Several studies have measured inter-
ventions to promote sleep in hospitalized patients (Alessi et al., 
2005; LaReau, Benson, Watcharotone, & Manguba, 2008; Martin, 
Marler, Harker, Josephson, & Alessi, 2007; Richards, O’Sullivan, 
& Phillips, 2000); however, no evidence-based interventions for 
sleep-wake disturbances exist that are categorized as recom-
mended for practice by the Oncology Nursing Society’s (ONS’s) 
Putting Evidence Into Practice (PEP) program (Page & Berger, 
2009; Page, Berger, & Johnson, 2006; Pieszak, 2011). In addition, 
no studies were found that assessed sleep disturbances during 
inpatient hospitalization for HSCT. The literature review and 
findings of the PEP team were the catalyst for the development 
of the current descriptive study involving the HSCT population.
Limited studies have focused on sleep disturbances in recipi-
ents of HSCT. Andrykowski et al. (2005) found that survivors 
who had completed stem cell transplantation reported poorer 
outcomes in areas such as physical health, physical functioning, 
and psychological adjustment than a healthy control group. 
Survivors also reported more sleep problems and greater fatigue 
than the healthy control group. 
In another study, Andrykowski et al. (1997) assessed energy 
level and sleep quality in adult bone marrow transplantation sur-
vivors. They reported that 50%–66% of patients who were three 
to four years post-transplantation still experienced issues with 
energy levels or sleep disturbances. In another study following 
survivors who had completed stem cell transplantation, more than 
half of participants reported tiredness as one of the two most com-
mon disturbances (Edman, Larsen, Hägglund, & Gardulf, 2001). 
Only one study described the effect of sleep-wake disturbances on 
long-term hospitalized patients who received HSCT. Rischer, Sch-
erwath, Zander, Koch, and Schulz-Kindermann (2009) described 
sleep disturbances in the acute course of HSCT encompassing the 
time period around hospitalization. The study found that sleep 
problems were significantly worse during the inpatient hospital-
ization phase than at any other point (Rischer et al., 2009). 
ONS (2010) has developed PEP as a resource for oncology nurs-
es. The purpose of PEP is to improve oncology nursing-sensitive pa-
tient outcomes through resources that summarize evidence-based 
interventions for common clinical problems (Eaton & Tipton, 
2009). Integrating the most current evidence into practice is a pri-
ority for high-quality and cost-effective nursing care (ONS, 2010). 
Berger et al. (2005) summarized the findings of the 2004 ONS 
State of the Science conference on sleep-wake disturbances. 
During this session, a group of experts in the field of sleep-wake 
disturbances defined outcomes for sleep, reviewed the current 
literature for measurement tools, and identified studies that 
included interventions for sleep. Sleep-wake disturbances was 
added to the list of outcomes to be developed in the PEP pro-
gram as a resource for all nurses caring for patients with cancer 
(Page & Berger, 2009). For the current study, the authors used 
these cardsa as a framework to investigate sleep in hospitalized 
patients who receive stem cell transplantations. 
The specific question raised was: What factors contribute to 
sleep-wake disturbances in the inpatient setting in recipients of 
HSCT? The assumption directing the study was that recipients 
of HSCT are uniquely prone to sleep-wake disturbances because 
of their long hospitalizations, numerous medications, com-
plications experienced from the transplantation process, and 
complex psychosocial needs. The current study was designed 
to determine the sleep deficits present in the hospitalized stem 
cell transplantation population and the patients’ perceptions of 
the reasons behind the deficit.
Methods
Design 
A descriptive retrospective study design was used to deter-
mine the existence of a sleep disturbance in lengthy hospital-
izations for recipients of stem cell transplantations. The study 
aimed to identify level of sleep disturbance in the patient popu-
lation, identify factors contributing to decreased ability to sleep 
for hospitalized patients undergoing HSCT, and to compare the 
differences in sleep disturbance between age, gender, type of 
transplantation, and initial stem cell transplantation versus read-
mission for transplantation-associated complications. 
Measures
Several tools have been developed to assess sleep quality or 
sleep-wake disturbances (Buysse, Reynolds, Monk, Berman, & 
Kupfer, 1989; Ersser et al., 1999; Richardson, 1997; Richardson, 
Crow, Coghill, & Turnock, 2007). Two tools have been used 
to assess sleep disturbances in the oncology population: the 
Pittsburgh Sleep Quality Index and the Insomnia Severity Index 
(ISI) (Buysse et al., 1989; Savard, Savard, Simard, & Ivers, 2005). 
The ISI was chosen because of its straightforwardness and small 
time commitment from the patient. The ISI also was appropri-
ate because the scoring system easily classifies a patient within 
a range of insomnia. The ISI is a seven-item questionnaire that 
assesses patient perception of sleep pattern and quality over the 
prior two weeks. Patients scored each question, and responses 
ranged from 0 (not at all, very dissatisfied) to 4 (very much, very 
satisfied). The scores from each item were added to give a total 
score ranging from 0–28. A score of 0–7 indicates no clinically 
significant insomnia, 8–14 indicates subthreshold insomnia, 
15–21 indicates clinical insomnia of moderate severity, and a 
score of 22–28 indicates severe clinical insomnia (Bastien, Val-
lières, & Morin, 2001). 
In the current study, the authors were interested in the number 
of patients reporting subthreshold or clinical insomnia. The ISI 
has been clinically tested, and is a reliable and valid tool for assess-
ing patient perception of insomnia severity (Bastien et al., 2001). 
The questionnaire participants received included the ISI 
and one subjective question regarding the patient’s perceived 
reasons for insomnia. Demographic questions were included to 
better define the population affected by insomnia (see Figure 1). 
Study Population
Hospitalized recipients of all types of stem cell transplan-
tations, including autologous and allogeneic (e.g., related, 
a The Oncology Nursing Society’s Putting Evidence Into Practice cards were 
replaced in 2009 with Putting Evidence Into Practice: Improving Oncology 
Patient Outcomes (Eaton & Tipton, 2009).
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unrelated, cord blood), were eligible. Participants were re-
cruited for the study from the inpatient adult population of 
a hematopoietic transplantation unit of a large, academic, 
tertiary-care facility. Eligibility criteria included any stem cell 
transplantation recipient hospitalized for at least 14 days on 
the inpatient unit. Exclusion criteria included any patients 
who had a previously diagnosed sleep disorder or any length 
of stay in the intensive care unit during the prior 14 days of 
hospitalization.
Procedure
Institutional review board approval was attained. After 
verbal consent was obtained, participants were asked to com-
plete the assessment tool, including demographics, ISI, and 
the subjective question addressing the patient’s perception of 
factors contributing to their inability to sleep. Data collection 
occurred at or soon after the 14th day of hospitalization, but 
was reflective of the prior two weeks of hospitalization, as 
this was the timeframe the ISI was designed to measure. The 
tool was administered by trained transplantation staff nurses 
to eligible patients. 
Data Analysis
First, ISI scores were calculated on all patients and the descrip-
tive statistics were examined. The authors then examined the 
distribution of patients who had subthreshold (ISI score = 8–14), 
clinical (ISI score = 15–21), or severe insomnia (ISI score = 
22–28). This classification was used for all subsequent analyses. 
Patients with clinical insomnia (moderate and severe) versus 
subthreshold insomnia were then compared by demographic 
characteristics using chi-square tests. Finally, the authors re-
stricted the analysis to the patients with subthreshold or clini-
cal insomnia and tabulated the patients’ reported reasons for 
disturbed sleep. 
Insomnia Severity Index
For each question, CIRCLE the number that best describes your answer. 
Please rate the current (last 2 weeks) severity of your insomnia problems.
Demographics
None Mild Moderate Severe
Very 
Severe
1. Difficulty falling 
asleep
0 1 2 3 4
2. Difficulty stay-
ing asleep 0 1 2 3 4
3. Problem waking 
up too early
0 1 2 3 4







0 1 2 3 4
5. How NOTICEABLE to others do you think your sleep problem is in 
terms of impairing the quality of your life?
Not at all 
noticable A little Somewhat Much Very Much
0 1 2 3 4
7. To what extent do you consider your sleep problem to INTEREFERE 
with your daily functioning (e.g., daytime fatigue, mood, ability to 
function, concentration, memory, mood) CURRENTLY?
Not at all 
interfering A little Somewhat Much Very Much
0 1 2 3 4
6. How WORRIED/DISTRESSED are you about your current sleep problem?
Not at all 
worried A little Somewhat Much Very Much
0 1 2 3 4
Figure 1. Sleep Study Questionnaire
Note. Insomnia Severity Index adapted with permission from Charles M. Morin.
1. Gender Male Female
2. Age 18–29 30–39 40–49 50–59
60–69 70–79 > 80








4. Admission type Initial transplant Readmission
5. Have you ever 
had a diagnosed 
sleep disorder?
Yes No
If you did experience sleep difficulties while hospitalized, in your opin-
ion, what were the contributing factors? 
o Staff interrupting for care (vital signs, lab draw, etc.)
o Frequent bathroom use (urine or diarrhea)
o Noise
o Anxiety about yourself (about transplant itself or about 
outcome)
o Anxiety thinking about others (parents, children, spouse, 
etc.)
o Uncontrolled physical symptoms (pain, nausea, etc.)
o
Other (Please specify.): ___________________________ 
_____________________________________________
Factors in Sleep Difficulties
Circle the best answer.
Check all that apply.
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Clinically significant insomnia (moderate)






Of 93 potential participants identified for the study, 69 
patients completed 73 surveys. Five patients completed two 
surveys each—one on initial admission for stem cell transplan-
tation and one when readmitted for transplantation-associated 
complications. Five patients declined to participate in the study. 
Two patients were excluded for having spent time in the in-
tensive care unit during their stay, and one patient’s confusion 
made completing the tool impossible and led to exclusion from 
the study. Sixteen patients were discharged before a study team 
member was able to approach them with a survey. 
Figure 2 shows the incidence of insomnia in the sample 
patient population. The mean ISI score was 10.9 (SD = 5.7), in-
dicating an average of subthreshold insomnia, and the median 
score was 11 (range = 0–25). Most patients had subthreshold 
insomnia or greater. 
Figure 3 illustrates the incidence of insomnia by demo-
graphics. Eighty-seven percent of women reported insomnia 
compared to 67% of men. Patients who received an autologous 
transplantation reported less insomnia than either type of 
allogeneic transplantation, which could be attributed to the 
fact that, at the 14th day of hospitalization, they were at differ-
ent phases of the treatment course. By that time, autologous 
patients are ready for discharge, whereas allogeneic patients 
still are recovering from their treatment and managing their 
symptoms. Neither of these trends was statistically significant. 
No difference was observed in reported insomnia based on 
age or type of admission. Patients were able to determine why 
their sleep was disturbed (see Table 1), and the most frequently 
reported reasons were frequent toileting (85%) and staff inter-
ruptions for care (80%). 
Limitations
The population assessed was a convenience sample of recipi-
ents of HSCT from one institution. A larger sample size with ad-
ditional study sites would have enabled the authors to see trends 
in each of the smaller demographic populations reviewed. 
Availability of study personnel and discharges before 14 days 
affected the ability to collect a larger sample. Small amounts of 
demographic data were omitted by patients. In future studies, 
data collectors could review the tool for completeness prior to 
submission. Another interesting step would be to measure sleep 
on admission as a baseline and again on the 14th day to identify 
problems that specifically arose during hospitalization. How-
ever, the data reported provide the HSCT nursing community 
with findings that may lead to interventions to improve sleep 
quality in this patient population. 
Nursing Implications
Nurses are in the position to influence patient-centered out-
comes in the hospital, including sleep. By enhancing sleep, nurses 
can help recipients of HSCT be in an optimal position to recover 
from chemotherapy, gain strength, fight infection, and enhance 
quality of life. Nurses can help promote sleep by encouraging 
Figure 3. Frequency of Insomnia by Demographics
Related—matched related donor transplantation; unrelated—matched 
unrelated donor transplantation
Note. Comparisons in demographics were examined using chi-square 
statistics.
Note. Two patients did not select their gender on the survey, so they 
were excluded from the demographic characteristics.  




























p = 0.19 p = 0.244
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toileting, helping the patient manage symptoms, providing 
medications when needed, and minimizing environmental noise. 
When nurses focus their interventions at bedtime, they provide 
an optimal sleep environment. Sleep is an important component 
of the recovery process. Based on the results of the ISI and the pa-
tients’ descriptions of sleep deficit, nurses need to acknowledge 
the importance of sleep and intervene to promote a high-quality 
sleep. Patients have their own ideas about why they are unable to 
get the proper sleep while hospitalized and the authors learned, 
through this study, not to project nurses’ ideas about why patients 
are not sleeping. The factors experienced by patients often are 
not noticed by nursing staff, and patient input is invaluable in as-
sessing and creating a plan to promote sleep.
Conclusions
Difficulty sleeping is a significant concern for patients under-
going HSCT. When looking at the contributing factors for sleep 
disturbance, it originally was predicted that noise would be the 
most significant issue reported by patients. In fact, noise was the 
least reported, whereas frequent bathroom use and staff inter-
ruptions for care were the most reported factors contributing to 
disturbed sleep. Interventions to promote sleep should focus on 
minimizing need for frequent toileting and interruptions by staff 
during the night hours. Interventions that could be tested in the 
future include grouping nursing care at night to minimize inter-
ruptions beyond scheduled hourly rounds and reinforcing rounds 
by nurses before bed, with a focus on encouraging bathroom use 
and alleviating physical symptoms. All patients in the current 
study had 24-hour continuous IV fluids running. To reduce night-
time bathroom use, collaborating with the medical team may be 
beneficial to decrease IV fluid rates at night when possible.
When nurses are aware of patients’ perceptions of sleep 
problems, they are in a better position to intervene. Patients 
can benefit from the nurses’ increased knowledge of contrib-
uting factors for sleep disturbance. Nurses have the ability to 
influence the environment to optimize conditions for sleep, 
therefore promoting health and healing after HSCT.
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